ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668258 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668258; 2) Community: the network communities that were significantly associated with the response to NSC 668258; 3) Molecule: the relationships between components within communities and NSC 668258; 4) MDR: the compounds that were significantly associated with the NSC 668258.

NSC Compound Enrichment Correlation
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 3.59672078575117e-005 0.81412935
NSC 8120 Claviform 3.59672078575118e-005 0.77768445
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 7.26447784739253e-005 0.49574001
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 7.90190265422245e-005 0.80074078
NSC 302035 Melampodin B acetate 7.90190265422256e-005 0.72362717
NSC 710365 Null 8.31228411274747e-005 0.55592992
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 8.31228411274755e-005 0.82266121
Total:101  Current:101    [First] [Prev] [Next] [Last]